Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
February 18 2021 - 9:00AM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following investor conferences:
10th Annual SVB Leerink Global Healthcare Conference
Fireside Chat Presentation: Friday, February 26, 2021 at 10:40 a.m.
Eastern Time
Cowen 41st Annual Health Care Conference Fireside Chat
Presentation: Monday, March 1, 2021 at 12:20 p.m. Eastern Time
These conferences will be held virtually. Live webcasts of the
presentations will be accessible on the company’s website,
www.acadia-pharm.com, under the investors section and an archived
recording will be available on the website for approximately one
month following each presentation.
About Acadia Pharmaceuticals Acadia is trailblazing
breakthroughs in neuroscience to elevate life. For more than 25
years we have been working at the forefront of healthcare to bring
vital solutions to people who need them most. We developed and
commercialized the first and only approved therapy for
hallucinations and delusions associated with Parkinson’s disease
psychosis. Our late-stage development efforts are focused on
dementia-related psychosis, negative symptoms of schizophrenia and
Rett syndrome, and in early-stage clinical research we are
exploring novel approaches to pain management, and cognition and
neuropsychiatric symptoms in central nervous system disorders. For
more information, visit us at www.acadia-pharm.com and follow us on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210218005241/en/
Media Contact: Acadia Pharmaceuticals Inc. Eric Endicott (858)
914-7161 media@acadia-pharm.com
Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024